Neurogenic factors in renal hypertension

Current Hypertension Reports

Volumn 4, Issue 3, 2002, Pages 256-260

  Campese, Vito M ^a   Krol, Ewa ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADRENERGIC SYSTEM; ANIMAL; BRAIN LEVEL; ENZYMOLOGY; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RENOVASCULAR HYPERTENSION; REVIEW;

ANIMALS; BRAIN CHEMISTRY; CYTOKINES; HUMANS; HYPERTENSION, RENAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0036615837     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-002-0016-3     Document Type: Article

References (53)

1. Campese V, MozaYeni P: Pathophysiology of hypertension in specific renal parenchymal diseases. In Clinical Nephrology, Dialysis and Transplantation. Edited by Malluche HH, Sawaya BP, Hakim RM, Sayegh MH. Dusti-Verlag Dr. Karl Feiste; 1999: 7-12.
2. Galla JH, Luke RG: Hypertension in renal parenchymal disease. In The Kidney. Edited by Brenner BM, Rector FC. Philadelphia: WB Saunders Company; 2000: 2035-2058.
3. Klag MJ, Whelton PK, Randall BL, et al.: Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334: 13-18.
4. Curtis JR, Eastwood JB, Smith EK: Maintenance hemodialysis. Q J Med 1969, 38: 49-89.
5. Schalekamp MADH, Schalekamp-Kuyken MPA, Demoor-Fruytier M, et al.: Interrelationships between blood pressure, renin, renin substrate and blood, in terminal renal failure. Clin Sci Mol Med 1973, 45: 417-428.
6. Lazarus JM, Hampers CL, Merrill JP: Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy. Arch Intern Med 1974, 133: 1059-1066.
7. Atuk NO, Bailey CJ, Turner S, et al.: Red blood cell catechol-o-methyl transferase, plasma catecholamines and renin in renal failure. Trans Am Soc Artif Intern Organs 1976, 22: 195-200.
8. Lake CR, Ziegler MG, Coleman MD, Kopin IJ: Plasma levels of norepinephrine and dopamine-beta-hydroxylase in CRF patients treated with dialysis. Cardiovasc Med 1979, 1: 1099-1111.
9. Henrich WL, Katz FH, Molinoff PB, Schrier RW: Competitive effects of hypokalemia and, depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients. Kidney Int 1977, 12: 279-284.
10. lzzo JL, Izzo MS, Sterns RH, Freeman RB: Sympathetic nervous system hyperactivity in maintenance hemodialysis patients. Trans Am Soc Artif Organs 1982, 28: 604-607.
11. Cuche JL, Prinseau J, Selz F, et al.: Plasma free, sulfo- and glucuro-conjugated catecholamines in uremic patients. Kidney Int 1986, 30: 566-572.
12. Campese VM, Romoff MS, Levitan D, et al.: Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981, 20: 246-253.
13. Ishii M, Ikeda T, Takagi M: Elevated plasma catecholamines in hypertensives with primary glomerular diseases. Hypertension 1983, 5: 545-551.
14. Converse RL, Jacobsen TN, Toto RD, et al.: Sympathetic overactivity in patients with CRF. N Engl J Med 1992, 327: 1912-1918.
15. Ye S, Ozgur B, Campese VM: Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997, 51: 722-727.
16. Bigazzi R, Kogosov E, Campese VM: Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol 1994, 4: 1901-1907.
17. Recordati G, Moss NG, Genovisi S, Rogenes P: Renal chemore-ceptors. J Auton Nerv Syst 1981, 3: 237-251.
18. Katholi RE: Renal nerves and hypertension: an update. Fed Proc 1985, 44: 2846-2850.
19. Dibona GF: The function of the renal nerves. Rev Physiol Biochem Pharmacol 1982, 94: 75-181.
20. Calaresu FR, Ciriello J: Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in cat. J Auton Nerv Syst 1981, 3: 311-320.
21. Ciriello J, Calaresu FR: Central projection of afferent renal fibers in the rat: an anterograde transport study of horseradish peroxidase. J Auton Nerv Syst 1983, 8: 273-285.
22. Katholi RE, Whitlow PL, Hageman GR, Woods T: Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves. J Hypertens 1984, 2: 349-359.
23. Katholi RE, Winternitz SR, Oparil S: Decrease in peripheral sympathetic nervous system activity following renal denervation or uncapping in the one-kidney one-clip Goldblatt hypertensive rat. J Clin Invest 1982, 69: 55-62.
24. Brody MJ, Johnson AK: Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation and hypertension. In Frontiers in Neuroendocrinology. Edited by Ganong WF. New York: Raven Press; 1980: 249-292.
25. Wyss JM, Aboukarsh N, Oparil S: Sensory denervation of the kidney attenuates renovascular hypertension in the rat. Am J Physiol 1986, 19: H82-H86.
26. Katholi RE, Naftilan AJ, Oparil S: Importance of renal sympathetic tone in the development of DOCA-salt hypertension in rat. Hypertension 1980, 2: 266-273.
27. Katholi RE, Winternitz SR, Oparil S: Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat. Hypertension 1981, 3: 404-409.
28. Jing-Yun P, Bishop VS, Ball NA, Haywood JR: Inability of dorsal spinal rhizotomy to prevent wrap hypertension in rats. Hypertension 1985, 7: 722-728.
29. Campese VM, Kogosov E, Koss M: Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 1995, 26: 861-865.
30. Klein IHHT, Ligtenberg G, Oey PL, et al.: Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 2001, 12: 2427-2433.
31. Kopp UC, Olson LA, Dibona GF: Renorenal reflex responses to mechano- and chemoreceptors stimulation in the dog and rat. Am J Physiol 1984, 241: R286-R292.
32. Calaresu FR, Kim P, Nakamura H, Sato A: Electrophysiological characteristics of renorenal reflexes in the cat. J Physiol 1978, 283: 141-154.
33. Faber JE, Brody MJ: Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res 1985, 57: 676-688.
34. Katholi RE, Whitlow PL, Hageman GR, Woods T: Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves. J Hypertens 1984, 2: 349-359.
35. Brody MJ, Johnson AK: Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation and hypertension. In Frontiers in Neuroendocrinology. Edited by Ganong WF New York: Raven Press; 1980: 249-292.
36. Ye S, Gumburd M, Campese VM: An acute renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens 1998, 11: 723-728.
37. Campese VM, Chanana A: Hypertension in dialysis patients. In Principles and Practice of Dialysis. Edited by Henricii WL. Baltimore: Williams & Wilkins; 1999: 209-234.
38. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neuronal role for nitric oxide. Nature 1990, 347: 768-770.
39. Vincent SR, Kimura H: Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992, 6: 755-784.
40. Tseng CJ, Liu HY, Lin HC, et al.: Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 1996, 27: 36-42.
41. Barinaga M: Is nitric oxide the "retrograde messenger"? Science 1991, 254: 1296-1297.
42. Togashi H, Sakuma I, Yoshioka M, et al.: A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 1992, 262: 343-347.
43. Harada S, Tokunaga S, Momohara M, et al.: Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 1993, 72: 511-516.
44. Ye S, Nosrati S, Campese VM: Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure. J Clin Invest 1997, 99: 540-548.
45. Vaziri ND, Ni Z, Wang XQ, et al.: Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol 1998, 274(4 Part 2): F642-F649.
46. Ichijo T, Katafuchi T, Hori T: Central interleukin-lb enhances splenic sympathetic nerve activity in rats. Brain Res Bull 1994, 34: 547-553.
47. Terao A, Oikawa M, Saito M: Tissue-specific increase in nore-pinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. Am J Physiol 1994, 266: R400-R404.
48. Niijima A, Hori T, Aou S, Oomura Y: The effects of interleukin-lb on the activity of adrenal splenic and renal sympathetic nerves in the rat. J Autonom Nerv Syst 1991, 36: 183-192.
49. Liu S, Adcock IM, Ols RW, et al.: Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 1993, 196: 1208-1213.
50. Robbins RA, Springall DR, Warren JB, et al.: Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 1994, 198: 835-843.
51. Tanazawa T, Suzuki Y, Anzai M, et al.: Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs. Acta Neurochir 1996, 138: 330-337.
52. Shibata M, Pazrffnova H, Zucherman SL, et al.: Interleukin-1 beta peptides induce cerebral pial arteriolar dilation in anesthetized newborn pigs. Am J Physiol 1996, 270: R1044-R1050.
53. Ye S, Mozayeni P, Gamburd M, et al.: Interleukin-1b and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am J Physiol 2000, 279: H2786-H2796.